A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

December 7, 2017

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

PT010

PT010; Budesonide, Glycopyrrolate, and Formoterol Fumarate Inhalation Aerosol. Administered as 2 inhalations per use as instructed per the protocol.

Trial Locations (1)

Research Site, Clearwater